{"pmid":32340997,"title":"Global regulatory agility during covid-19 and other health emergencies.","text":["Global regulatory agility during covid-19 and other health emergencies.","BMJ","Mak, Tippi K","Lim, John Cw","Thanaphollert, Prapassorn","Mahlangu, Gugu N","Cooke, Emer","Lumpkin, Murray M","32340997"],"journal":"BMJ","authors":["Mak, Tippi K","Lim, John Cw","Thanaphollert, Prapassorn","Mahlangu, Gugu N","Cooke, Emer","Lumpkin, Murray M"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340997","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/bmj.m1575","topics":["Prevention"],"weight":1,"_version_":1665351883912380416,"score":8.574329,"similar":[{"pmid":32197238,"title":"Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.","text":["Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.","The first confirmed case of coronavirus disease 2019 (COVID-19) in the United States was reported on January 20, 2020, in Snohomish County, Washington. At the epicenter of COVID-19 in the United States, the Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, and University of Washington are at the forefront of delivering care to patients with cancer during this public health crisis. This Special Feature highlights the unique circumstances and challenges of cancer treatment amidst this global pandemic, and the importance of organizational structure, preparation, agility, and a shared vision for continuing to provide cancer treatment to patients in the face of uncertainty and rapid change.","J Natl Compr Canc Netw","Ueda, Masumi","Martins, Renato","Hendrie, Paul C","McDonnell, Terry","Crews, Jennie R","Wong, Tracy L","McCreery, Brittany","Jagels, Barbara","Crane, Aaron","Byrd, David R","Pergam, Steven A","Davidson, Nancy E","Liu, Catherine","Stewart, F Marc","32197238"],"abstract":["The first confirmed case of coronavirus disease 2019 (COVID-19) in the United States was reported on January 20, 2020, in Snohomish County, Washington. At the epicenter of COVID-19 in the United States, the Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, and University of Washington are at the forefront of delivering care to patients with cancer during this public health crisis. This Special Feature highlights the unique circumstances and challenges of cancer treatment amidst this global pandemic, and the importance of organizational structure, preparation, agility, and a shared vision for continuing to provide cancer treatment to patients in the face of uncertainty and rapid change."],"journal":"J Natl Compr Canc Netw","authors":["Ueda, Masumi","Martins, Renato","Hendrie, Paul C","McDonnell, Terry","Crews, Jennie R","Wong, Tracy L","McCreery, Brittany","Jagels, Barbara","Crane, Aaron","Byrd, David R","Pergam, Steven A","Davidson, Nancy E","Liu, Catherine","Stewart, F Marc"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32197238","week":"202012|Mar 16 - Mar 22","doi":"10.6004/jnccn.2020.7560","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["United States","Snohomish County","Washington","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664640930757476352,"score":53.461136},{"pmid":32277907,"title":"Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.","text":["Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.","Lancet Oncol","de Paula, Bruno H R","Araujo, Indiara","Bandeira, Livia","Barreto, Nathalia M P B","Doherty, Gary J","32277907"],"journal":"Lancet Oncol","authors":["de Paula, Bruno H R","Araujo, Indiara","Bandeira, Livia","Barreto, Nathalia M P B","Doherty, Gary J"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277907","week":"202015|Apr 06 - Apr 12","doi":"10.1016/S1470-2045(20)30226-6","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636943960375296,"score":49.41108},{"pmid":32319884,"title":"Extended use or reuse of N95 respirators during COVID-19 pandemic: an overview of national regulatory authorities' recommendations.","text":["Extended use or reuse of N95 respirators during COVID-19 pandemic: an overview of national regulatory authorities' recommendations.","Infect Control Hosp Epidemiol","Kobayashi, Leticia Mitiko","Marins, Bianca Ramos","Costa, Patricia Cristina Dos Santos","Perazzo, Hugo","Castro, Rodolfo","32319884"],"journal":"Infect Control Hosp Epidemiol","authors":["Kobayashi, Leticia Mitiko","Marins, Bianca Ramos","Costa, Patricia Cristina Dos Santos","Perazzo, Hugo","Castro, Rodolfo"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32319884","week":"202017|Apr 20 - Apr 26","doi":"10.1017/ice.2020.173","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664815087777480704,"score":43.90835},{"pmid":32334979,"title":"The pandemic of COVID-19 and its implications for the purity and authenticity of alcohol-based hand sanitizers: The health risks associated with falsified sanitizers and recommendations for regulatory and public health bodies.","text":["The pandemic of COVID-19 and its implications for the purity and authenticity of alcohol-based hand sanitizers: The health risks associated with falsified sanitizers and recommendations for regulatory and public health bodies.","With the beginning of the pandemic of COVID-19 throughout the world, the demand and consumption of hand sanitizers has increased, which had led to a sharp crunch in these products at all levels. This shortage has led to an increase in the prevalence of falsified alcohol-based hand sanitizers, including the illegal addition of methanol to hand sanitizers and the production of hand sanitizers with an alcohol concentration of less than 60%. These findings indicate that regulatory and public health bodies should take an active role in ensuring the safety and quality of antimicrobial products such as alcohol-based hand sanitizers at every stage of the products' lifecycle, including distribution, manufacture and import.","Res Social Adm Pharm","Jairoun, Ammar Abdulrahman","Al-Hemyari, Sabaa Saleh","Shahwan, Moyad","32334979"],"abstract":["With the beginning of the pandemic of COVID-19 throughout the world, the demand and consumption of hand sanitizers has increased, which had led to a sharp crunch in these products at all levels. This shortage has led to an increase in the prevalence of falsified alcohol-based hand sanitizers, including the illegal addition of methanol to hand sanitizers and the production of hand sanitizers with an alcohol concentration of less than 60%. These findings indicate that regulatory and public health bodies should take an active role in ensuring the safety and quality of antimicrobial products such as alcohol-based hand sanitizers at every stage of the products' lifecycle, including distribution, manufacture and import."],"journal":"Res Social Adm Pharm","authors":["Jairoun, Ammar Abdulrahman","Al-Hemyari, Sabaa Saleh","Shahwan, Moyad"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32334979","week":"202018|Apr 27 - May 03","doi":"10.1016/j.sapharm.2020.04.014","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1665172302022574080,"score":43.33468},{"pmid":32314951,"title":"Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.","text":["Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.","We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.","Subst Abus","Green, Traci C","Bratberg, Jeffrey","Finnell, Deborah S","32314951"],"abstract":["We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased."],"journal":"Subst Abus","authors":["Green, Traci C","Bratberg, Jeffrey","Finnell, Deborah S"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314951","week":"202017|Apr 20 - Apr 26","doi":"10.1080/08897077.2020.1752351","keywords":["pandemic","buprenorphine","methadone","opioid use disorder","pharmacists","policy","regulations"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520137826305,"score":42.364426}]}